News

03.01.21

SARS CoV-2 Mutations Provide Clues on Origins, Spread

Read More

News

01.08.21

GEN Article: Supercharge Antibody Discovery Workflows with High-Throughput SPR

Read More

News

12.14.20

PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization

Read More

News

12.01.20

Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairman of the Board of Directors

Read More

News

08.17.20

Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-free Assay

Read More

News

07.06.20

GEN Article: Eliminating Bottlenecks in mAb Drug Discovery

Twist Biopharma screens massive antibody libraries with the Carterra LSA to discover therapeutic antibodies in just weeks.

Read More

News

06.29.20

Podcast: Tim Germann our Chief Commercial Officer Discusses how Carterra has Become an Innovator and Driving Force in Therapeutic Antibody Discovery

Listen to Podcast

News

06.18.20

Nature Article: Speeding Antibody Screening for Drug Development

Advanced screening technology can dramatically accelerate the hunt for effective treatments for cancer, COVID-19 and more.

Read More

News

04.09.20

Video: Carterra has been Selected by the Gates Foundation to Help Solve the COVID-19 Pandemic

Watch Video

News

03.31.20

Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Read More